PL371382A1 - Połączenia epinastyny, Belladony i pseudoefedrynyjako nowe preparaty farmaceutyczne - Google Patents

Połączenia epinastyny, Belladony i pseudoefedrynyjako nowe preparaty farmaceutyczne

Info

Publication number
PL371382A1
PL371382A1 PL03371382A PL37138203A PL371382A1 PL 371382 A1 PL371382 A1 PL 371382A1 PL 03371382 A PL03371382 A PL 03371382A PL 37138203 A PL37138203 A PL 37138203A PL 371382 A1 PL371382 A1 PL 371382A1
Authority
PL
Poland
Prior art keywords
belladonna
epinastine
pseudoephedrine
combinations
pharmaceutical formulations
Prior art date
Application number
PL03371382A
Other languages
English (en)
Inventor
Noritaka Seko
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL371382A1 publication Critical patent/PL371382A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL03371382A 2002-04-03 2003-03-28 Połączenia epinastyny, Belladony i pseudoefedrynyjako nowe preparaty farmaceutyczne PL371382A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PL371382A1 true PL371382A1 (pl) 2005-06-13

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371382A PL371382A1 (pl) 2002-04-03 2003-03-28 Połączenia epinastyny, Belladony i pseudoefedrynyjako nowe preparaty farmaceutyczne

Country Status (12)

Country Link
US (1) US20030228359A1 (pl)
EP (2) EP1350512A1 (pl)
JP (1) JP2005522467A (pl)
AR (1) AR039221A1 (pl)
AU (1) AU2003221532A1 (pl)
BR (1) BR0308982A (pl)
CA (1) CA2477751A1 (pl)
MX (1) MXPA04009582A (pl)
PE (1) PE20040080A1 (pl)
PL (1) PL371382A1 (pl)
RU (1) RU2004132205A (pl)
WO (1) WO2003082285A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
CN1738610A (zh) * 2003-01-22 2006-02-22 日绊株式会社 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法
MXPA06003320A (es) * 2003-09-24 2006-06-08 Combinatorx Inc Regimenes terapeuticos para administrar combinaciones de farmacos.
CA2552458A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
US8298591B2 (en) * 2008-09-10 2012-10-30 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2554740C2 (ru) * 2009-05-01 2015-06-27 Апталис Фарматек, Инк. Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
EP1492532A1 (en) 2005-01-05
JP2005522467A (ja) 2005-07-28
MXPA04009582A (es) 2005-01-11
PE20040080A1 (es) 2004-04-22
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
RU2004132205A (ru) 2005-09-10
AU2003221532A1 (en) 2003-10-13
AR039221A1 (es) 2005-02-09
CA2477751A1 (en) 2003-10-09
EP1350512A1 (en) 2003-10-08
BR0308982A (pt) 2005-01-04

Similar Documents

Publication Publication Date Title
HUP0402566A3 (en) C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
EP1435894A4 (en) CYTOPROTECTIVE COMPOUNDS, METHODS AND PHARMACEUTICAL AND COSMETIC FORMULATIONS
EP1552833A4 (en) STABLE SOLID PREPARATIONS
PL375833A1 (pl) Farmaceytyczne preparaty modafinilu
AU2003248721A1 (en) Adsorbents, methods of preparation, and methods of use thereof
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
AU2003220361A1 (en) Benzamides and compositions benzamides for use as fungizide
IL167187A (en) Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
HK1074446A1 (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
AU2003279911A1 (en) Therapeutic formulations
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
AU2003289742A1 (en) Stable therapeutic proteins
PL371382A1 (pl) Połączenia epinastyny, Belladony i pseudoefedrynyjako nowe preparaty farmaceutyczne
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
EP1617810A4 (en) PROCESS FOR THE PREPARATION AND USE OF 1ALPHA, 24 (S) -DIHYDROXYVITAMINE D2
AU2003250073A1 (en) Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
GB0326221D0 (en) Therapeutic agents,compositions,preparations and uses
AU2003225642A1 (en) Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
AU2002315931A1 (en) Heterodimeric conjugates of neomycin-oxazolidinone, their preparation and their use
AU2003281485A1 (en) Hair care composition

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)